<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>HRT Clinical Companion | Quick Reference</title>
    <style>
        :root {
            /* Color Palette */
            --primary-blue: #3498db;
            --primary-dark: #2980b9;
            --danger-red: #e74c3c;
            --danger-bg: #fadbd8;
            --success-green: #2ecc71;
            --success-bg: #d5f5e3;
            --neutral-gray: #95a5a6;
            --bg-color: #f4f7f6;
            --card-bg: #ffffff;
            --text-main: #2c3e50;
            --text-light: #7f8c8d;
            --shadow: 0 4px 6px rgba(0,0,0,0.1);
            --transition: all 0.3s ease;
        }

        * {
            box-sizing: border-box;
            margin: 0;
            padding: 0;
        }

        body {
            font-family: 'Segoe UI', Roboto, Helvetica, Arial, sans-serif;
            background-color: var(--bg-color);
            color: var(--text-main);
            line-height: 1.6;
            font-size: 16px;
        }

        /* --- Layout & Container --- */
        .app-container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
            display: grid;
            grid-template-rows: auto auto 1fr;
            min-height: 100vh;
        }

        /* --- Header & Search --- */
        header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 20px;
            flex-wrap: wrap;
            gap: 15px;
        }

        .logo-area h1 {
            font-size: 1.8rem;
            color: var(--text-main);
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .logo-icon {
            color: var(--primary-blue);
        }

        .search-bar {
            flex-grow: 1;
            max-width: 400px;
            position: relative;
        }

        .search-bar input {
            width: 100%;
            padding: 12px 15px 12px 40px;
            border-radius: 30px;
            border: 1px solid #ddd;
            background: white;
            font-size: 1rem;
            transition: var(--transition);
        }

        .search-bar input:focus {
            outline: none;
            border-color: var(--primary-blue);
            box-shadow: 0 0 0 3px rgba(52, 152, 219, 0.2);
        }

        .search-icon {
            position: absolute;
            left: 15px;
            top: 50%;
            transform: translateY(-50%);
            color: var(--text-light);
        }

        /* --- Navigation Tabs --- */
        .nav-tabs {
            display: flex;
            gap: 10px;
            margin-bottom: 25px;
            overflow-x: auto;
            padding-bottom: 5px;
        }

        .tab-btn {
            background: transparent;
            border: none;
            padding: 10px 20px;
            font-size: 1rem;
            font-weight: 600;
            color: var(--text-light);
            cursor: pointer;
            border-radius: 8px;
            transition: var(--transition);
            white-space: nowrap;
            display: flex;
            align-items: center;
            gap: 8px;
        }

        .tab-btn:hover {
            background: rgba(0,0,0,0.05);
            color: var(--primary-blue);
        }

        .tab-btn.active {
            background: var(--primary-blue);
            color: white;
            box-shadow: 0 2px 4px rgba(52, 152, 219, 0.3);
        }

        /* --- Content Area --- */
        .content-section {
            display: none;
            animation: fadeIn 0.4s ease-in-out;
        }

        .content-section.active {
            display: block;
        }

        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(10px); }
            to { opacity: 1; transform: translateY(0); }
        }

        /* --- Cards & Grid System --- */
        .grid-2 {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 20px;
        }

        .grid-3 {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 20px;
        }

        .card {
            background: var(--card-bg);
            border-radius: 12px;
            padding: 20px;
            box-shadow: var(--shadow);
            border-left: 5px solid transparent;
            transition: var(--transition);
            position: relative;
        }

        .card:hover {
            transform: translateY(-3px);
            box-shadow: 0 8px 15px rgba(0,0,0,0.1);
        }

        .card h3 {
            margin-bottom: 12px;
            font-size: 1.2rem;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .card p, .card li {
            font-size: 0.95rem;
            color: var(--text-main);
        }

        .card ul {
            padding-left: 20px;
            margin-top: 10px;
        }

        /* --- Color Modifiers --- */
        .card.danger {
            border-left-color: var(--danger-red);
            background: #fffdfd;
        }

        .card.danger h3 {
            color: var(--danger-red);
        }

        .card.success {
            border-left-color: var(--success-green);
            background: #fcfefc;
        }

        .card.success h3 {
            color: var(--success-green);
        }

        .card.info {
            border-left-color: var(--primary-blue);
        }

        .card.info h3 {
            color: var(--primary-blue);
        }

        /* --- Banners --- */
        .banner {
            padding: 15px;
            border-radius: 8px;
            margin-bottom: 20px;
            display: flex;
            align-items: flex-start;
            gap: 15px;
            font-weight: 500;
        }

        .banner.red-banner {
            background-color: var(--danger-bg);
            color: #c0392b;
            border: 1px solid #f5b7b1;
        }

        .banner.green-banner {
            background-color: var(--success-bg);
            color: #27ae60;
            border: 1px solid #abebc6;
        }

        /* --- Tables --- */
        .data-table-container {
            overflow-x: auto;
            background: white;
            border-radius: 12px;
            box-shadow: var(--shadow);
        }

        table {
            width: 100%;
            border-collapse: collapse;
            min-width: 600px;
        }

        th, td {
            padding: 15px;
            text-align: left;
            border-bottom: 1px solid #eee;
        }

        th {
            background-color: #f8f9fa;
            color: var(--text-light);
            font-weight: 700;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.5px;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* --- Chips/Tags --- */
        .tag {
            display: inline-block;
            padding: 4px 10px;
            border-radius: 20px;
            font-size: 0.75rem;
            font-weight: 700;
            text-transform: uppercase;
        }

        .tag.red { background: var(--danger-bg); color: var(--danger-red); }
        .tag.green { background: var(--success-bg); color: var(--success-green); }
        .tag.blue { background: #ebf5fb; color: var(--primary-blue); }

        /* --- Footer --- */
        footer {
            margin-top: 40px;
            text-align: center;
            font-size: 0.85rem;
            color: var(--text-light);
            padding-bottom: 20px;
        }

        /* --- Utilities --- */
        .highlight-text {
            background-color: #fff3cd;
            padding: 0 4px;
            border-radius: 2px;
        }

        .stat-box {
            display: flex;
            flex-direction: column;
            align-items: flex-start;
            margin-top: 10px;
        }
        
        .stat-val {
            font-size: 1.5rem;
            font-weight: bold;
        }

        .stat-desc {
            font-size: 0.85rem;
            color: var(--text-light);
        }

        /* Mobile Adjustments */
        @media (max-width: 768px) {
            .header { flex-direction: column; align-items: stretch; }
            .grid-2, .grid-3 { grid-template-columns: 1fr; }
        }
    </style>
</head>
<body>

<div class="app-container">

    <!-- Header -->
    <header>
        <div class="logo-area">
            <h1>
                <svg width="32" height="32" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="logo-icon"><path d="M22 12h-4l-3 9L9 3l-3 9H2"/></svg>
                HRT Clinical Companion
            </h1>
        </div>
        <div class="search-bar">
            <svg class="search-icon" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><circle cx="11" cy="11" r="8"></circle><line x1="21" y1="21" x2="16.65" y2="16.65"></line></svg>
            <input type="text" id="searchInput" placeholder="Search symptoms, risks, or drugs..." onkeyup="filterContent()">
        </div>
    </header>

    <!-- Navigation -->
    <nav class="nav-tabs">
        <button class="tab-btn active" onclick="switchTab('tab-dashboard', this)">
            <svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><rect x="3" y="3" width="7" height="7"></rect><rect x="14" y="3" width="7" height="7"></rect><rect x="14" y="14" width="7" height="7"></rect><rect x="3" y="14" width="7" height="7"></rect></svg>
            Dashboard
        </button>
        <button class="tab-btn" onclick="switchTab('tab-indications', this)">
            <svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M22 11.08V12a10 10 0 1 1-5.93-9.14"></path><polyline points="22 4 12 14.01 9 11.01"></polyline></svg>
            Indications
        </button>
        <button class="tab-btn" onclick="switchTab('tab-benefits', this)">
            <svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20.84 4.61a5.5 5.5 0 0 0-7.78 0L12 5.67l-1.06-1.06a5.5 5.5 0 0 0-7.78 7.78l1.06 1.06L12 21.23l7.78-7.78 1.06-1.06a5.5 5.5 0 0 0 0-7.78z"></path></svg>
            Benefits
        </button>
        <button class="tab-btn" onclick="switchTab('tab-risks', this)">
            <svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M10.29 3.86L1.82 18a2 2 0 0 0 1.71 3h16.94a2 2 0 0 0 1.71-3L13.71 3.86a2 2 0 0 0-3.42 0z"></path><line x1="12" y1="9" x2="12" y2="13"></line><line x1="12" y1="17" x2="12.01" y2="17"></line></svg>
            Risks & Safety
        </button>
        <button class="tab-btn" onclick="switchTab('tab-management', this)">
            <svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><circle cx="12" cy="12" r="10"></circle><polyline points="12 6 12 12 16 14"></polyline></svg>
            Management
        </button>
    </nav>

    <!-- Main Content Area -->
    <main>

        <!-- 1. DASHBOARD TAB -->
        <section id="tab-dashboard" class="content-section active">
            
            <div class="banner red-banner">
                <svg width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10.29 3.86L1.82 18a2 2 0 0 0 1.71 3h16.94a2 2 0 0 0 1.71-3L13.71 3.86a2 2 0 0 0-3.42 0z"></path><line x1="12" y1="9" x2="12" y2="13"></line><line x1="12" y1="17" x2="12.01" y2="17"></line></svg>
                <div>
                    <strong>Immediate Action:</strong> Women with a uterus must NOT take oestrogen-only HRT (High Endometrial Cancer Risk). Add cyclical progestogen or use continuous combined HRT.
                </div>
            </div>

            <div class="grid-2">
                <div class="card success">
                    <h3>
                        <svg width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M14 9V5a3 3 0 0 0-3-3l-4 9v11h11.28a2 2 0 0 0 2-1.7l1.38-9a2 2 0 0 0-2-2.3zM7 22H4a2 2 0 0 1-2-2v-7a2 2 0 0 1 2-2h3"></path></svg>
                        Primary Indication
                    </h3>
                    <p>Relief of <strong>Vasomotor Symptoms (VMS)</strong> (hot flushes/night sweats) affecting 80% of women. 25% report severe impact on QoL.</p>
                    <div class="stat-box">
                        <span class="stat-val">&lt; 3 months</span>
                        <span class="stat-desc">Time to maximum benefit</span>
                    </div>
                </div>

                <div class="card danger">
                    <h3>
                        <svg width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20.84 4.61a5.5 5.5 0 0 0-7.78 0L12 5.67l-1.06-1.06a5.5 5.5 0 0 0-7.78 7.78l1.06 1.06L12 21.23l7.78-7.78 1.06-1.06a5.5 5.5 0 0 0 0-7.78z"></path></svg>
                        Critical VTE Risk
                    </h3>
                    <p><strong>Oral HRT:</strong> Doubles risk of Venous Thromboembolism.</p>
                    <p><strong>Action:</strong> Offer <strong>Transdermal HRT</strong> (standard therapeutic dose) for women with BMI &ge; 30 or other risk factors.</p>
                </div>
            </div>

            <br>
            <h3>Quick Reference: Risk vs Benefit Snapshot</h3>
            <div class="data-table-container" style="margin-top: 15px;">
                <table>
                    <thead>
                        <tr>
                            <th>Condition</th>
                            <th>Impact of HRT</th>
                            <th>Action/Note</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Breast Cancer</strong></td>
                            <td><span class="tag red">Risk Increased</span></td>
                            <td>Extra cases vary by type. Lowest risk with Oestrogen-only.</td>
                        </tr>
                        <tr>
                            <td><strong>Osteoporosis</strong></td>
                            <td><span class="tag green">Risk Decreased</span></td>
                            <td>Effective prevention and treatment.</td>
                        </tr>
                        <tr>
                            <td><strong>CHD / Stroke</strong></td>
                            <td><span class="tag blue">Neutral / Complex</span></td>
                            <td>Transdermal preferred for arterial risk factors. Age <60 start time is key.</td>
                        </tr>
                        <tr>
                            <td><strong>Endometrial Cancer</strong></td>
                            <td><span class="tag red">High Risk (E-only)</span></td>
                            <td>Must add progestogen if uterus present.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </section>

        <!-- 2. INDICATIONS TAB -->
        <section id="tab-indications" class="content-section">
            <div class="grid-2">
                <div class="card info">
                    <h3>Core Indications</h3>
                    <ul>
                        <li><strong>Vasomotor Symptoms (VMS):</strong> Hot flushes and night sweats (lasts >7 yrs for >50% women).</li>
                        <li><strong>Genitourinary Syndrome (GSM):</strong> Atrophic vaginitis, urogenital atrophy.</li>
                        <li><strong>Under 45 Menopause:</strong> High risk of osteoporosis.</li>
                        <li><strong>Under 40 (POI):</strong> Continue until ~50 years (natural menopause age).</li>
                    </ul>
                </div>

                <div class="card success">
                    <h3>Treatment Types</h3>
                    <p><strong>Oestrogen (+ Progestogen):</strong><br>For women with a uterus to prevent endometrial hyperplasia.</p>
                    <hr style="margin: 10px 0; border:0; border-top:1px solid #eee;">
                    <p><strong>Tibolone:</strong><br>Post-menopausal use. Combines oestrogenic, progestogenic, and weak androgenic activity.</p>
                    <hr style="margin: 10px 0; border:0; border-top:1px solid #eee;">
                    <p><strong>Raloxifene:</strong><br>For osteoporosis only (does <strong>NOT</strong> reduce VMS).</p>
                </div>
            </div>

            <div class="card info" style="margin-top: 20px;">
                <h3>When NOT to use (Contra-indications)</h3>
                <div class="grid-2">
                    <div>
                        <ul>
                            <li>Pregnancy / Breastfeeding</li>
                            <li>Undiagnosed vaginal bleeding</li>
                            <li>Current / history of breast cancer (refer to specialist)</li>
                        </ul>
                    </div>
                    <div>
                        <ul>
                            <li>History of VTE (unless anticoagulated)</li>
                            <li>Active arterial disease</li>
                            <li>Severe active liver disease</li>
                        </ul>
                    </div>
                </div>
            </div>
        </section>

        <!-- 3. BENEFITS TAB -->
        <section id="tab-benefits" class="content-section">
            <div class="grid-3">
                <div class="card success">
                    <h3>
                        <svg width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M22 11.08V12a10 10 0 1 1-5.93-9.14"></path><polyline points="22 4 12 14.01 9 11.01"></polyline></svg>
                        VMS Reduction
                    </h3>
                    <p>Most effective treatment available.</p>
                    <div class="stat-box">
                        <span class="stat-val">80%</span>
                        <span class="stat-desc">Report symptoms alleviated</span>
                    </div>
                </div>

                <div class="card success">
                    <h3>
                        <svg width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M43 20a2 2 0 0 0-2-2v-8a2 2 0 0 0-2-2h-6l2-4h-4l-2 4h-4l-2-4H9l2 4H7a2 2 0 0 0-2 2v8a2 2 0 0 0-2 2h4"></path><path d="M22 17h-4"></path></svg>
                        Bone Health
                    </h3>
                    <p>Reduces risk of fragility fractures.</p>
                    <p>Benefit maintained during treatment but decreases once stopped.</p>
                </div>

                <div class="card success">
                    <h3>
                        <svg width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20.21 15.89A10 10 0 1 1 8 2.83"></path><path d="M22 12A10 10 0 0 0 12 2v10z"></path></svg>
                        Quality of Life
                    </h3>
                    <p>Improves sleep, muscle aches/pains, and mood.</p>
                    <p>Consider for low mood arising from menopause (CBT may also help).</p>
                </div>

                <div class="card success">
                    <h3>
                        <svg width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M12 2.69l5.74 5.88-5.74 5.88-5.74-5.88z"></path><path d="M12 22.5l-8.5-8.5"></path></svg>
                        GSM Improvement
                    </h3>
                    <p>Topical oestrogen improves urinary symptoms.</p>
                    <p>Vaginal atrophy reduced, pH normalized.</p>
                </div>

                <div class="card success">
                    <h3>
                        <svg width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20.42 4.58a5.4 5.4 0 0 0-7.65 0l-.77.78-.77-.78a5.4 5.4 0 0 0-7.65 0C1.46 6.7 1.33 10.28 4 13l8 8 8-8c2.67-2.72 2.54-6.3.42-8.42z"></path></svg>
                        Cardiovascular
                    </h3>
                    <p>Starting HRT <60 or within 10 years of menopause may reduce risk of CHD and all-cause mortality (BMS view).</p>
                    <p class="text-sm" style="font-size:0.8rem; margin-top:5px; color:#666;">*Note: NICE discussion aid suggests 1 extra case of CHD per 1000 women over 5 years.</p>
                </div>
            </div>
        </section>

        <!-- 4. RISKS TAB -->
        <section id="tab-risks" class="content-section">
            
            <!-- Critical Alert Banner -->
            <div class="banner red-banner">
                <strong>Breast Cancer Risk (NICE 2024 Update):</strong> Extra cases over 20 years (from age 50):<br>
                1 in 50 (Continuous Combined) | 1 in 70 (Sequential) | 1 in 200 (Oestrogen Only).
            </div>

            <div class="grid-2">
                <!-- Card: VTE -->
                <div class="card danger">
                    <h3>Venous Thromboembolism (VTE)</h3>
                    <div style="display:flex; gap:10px; margin-bottom:10px;">
                        <span class="tag red">Oral: Higher Risk</span>
                        <span class="tag green">Transdermal: Safe</span>
                    </div>
                    <p><strong>Recommendation:</strong> Use Transdermal HRT for women with BMI &ge; 30.</p>
                </div>

                <!-- Card: Stroke -->
                <div class="card danger">
                    <h3>Stroke & CHD</h3>
                    <p><strong>Baseline Risk:</strong> Depends on cardiovascular factors.</p>
                    <p><strong>NICE 2024:</strong> CHD risk may not increase with combined HRT, but risk of stroke is slightly increased.</p>
                    <p><strong>Recommendation:</strong> Transdermal preferred for arterial risk factors.</p>
                </div>

                <!-- Card: Ovarian Cancer -->
                <div class="card danger">
                    <h3>Ovarian Cancer</h3>
                    <p>Meta-analysis (2015) showed increased risk even with <5 years use.</p>
                    <div class="stat-box">
                        <span class="stat-val">1 in 1,000</span>
                        <span class="stat-desc">Extra ovarian cancer users</span>
                    </div>
                    <div class="stat-box" style="margin-top:5px;">
                        <span class="stat-val">1 in 1,700</span>
                        <span class="stat-desc">Extra ovarian cancer deaths</span>
                    </div>
                </div>

                <!-- Card: Dementia -->
                <div class="card danger">
                    <h3>Dementia</h3>
                    <p>Risk slightly increased if HRT started at age 65+.</p>
                    <p><strong>Context:</strong> Limited relevance to UK practice as starting >65 is uncommon.</p>
                </div>
            </div>

            <br>
            <h3>Breast Cancer Detailed View</h3>
            <div class="data-table-container" style="margin-top: 15px;">
                <table>
                    <thead>
                        <tr>
                            <th>HRT Type</th>
                            <th>Extra Cases (20 yrs)</th>
                            <th>Notes</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Continuous Combined</strong></td>
                            <td>1 per 50 users</td>
                            <td>Highest relative risk among HRT types.</td>
                        </tr>
                        <tr>
                            <td><strong>Sequential Combined</strong></td>
                            <td>1 per 70 users</td>
                            <td>Common for perimenopausal women.</td>
                        </tr>
                        <tr>
                            <td><strong>Oestrogen Only</strong></td>
                            <td>1 per 200 users</td>
                            <td>Lowest risk. BMS states 'little or no change' risk.</td>
                        </tr>
                        <tr>
                            <td><strong>Vaginal Oestrogen</strong></td>
                            <td>None observed</td>
                            <td>Safe for women with history of breast cancer (usually).</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </section>

        <!-- 5. MANAGEMENT TAB -->
        <section id="tab-management" class="content-section">
            <div class="grid-2">
                <div class="card info">
                    <h3>Contraception & HRT</h3>
                    <div class="banner red-banner" style="margin-bottom:10px; padding:10px;">
                        <strong>HRT is NOT a contraceptive.</strong>
                    </div>
                    <ul>
                        <li><strong>Aged &lt;50:</strong> Fertile for 2 years after last period.</li>
                        <li><strong>Aged &ge;50:</strong> Fertile for 1 year after last period.</li>
                        <li><strong>Women 50+:</strong> Do NOT prescribe Combined Oral Contraceptive Pill.</li>
                        <li><strong>Combo Option:</strong> Oestrogen HRT + Levonorgestrel IUS (Mirena) is optimal.</li>
                    </ul>
                </div>

                <div class="card info">
                    <h3>Follow-Up Schedule</h3>
                    <ul>
                        <li><strong>Initial Review:</strong> 3 months after starting or changing HRT. Check effectiveness & side-effects.</li>
                        <li><strong>Routine Review:</strong> At least annually thereafter.</li>
                        <li><strong>Critical Check:</strong> Ensure women with uterus are not taking unopposed oestrogen.</li>
                        <li><strong>Duration:</strong> Topical oestrogen for GSM usually continued long-term.</li>
                    </ul>
                </div>
            </div>

            <div class="card info" style="margin-top: 20px;">
                <h3>Quick Management Actions</h3>
                <div class="grid-3">
                    <div style="text-align:center; padding:10px; border:1px solid #eee; border-radius:8px;">
                        <span class="tag green">Safe Action</span>
                        <p style="margin-top:10px;"><strong>Switch to Transdermal:</strong> If BMI rises or VTE risk factors develop.</p>
                    </div>
                    <div style="text-align:center; padding:10px; border:1px solid #eee; border-radius:8px;">
                        <span class="tag green">Safe Action</span>
                        <p style="margin-top:10px;"><strong>Add Progestogen:</strong> Switching from sequential to continuous combined after 1-5 years removes endometrial cancer risk.</p>
                    </div>
                    <div style="text-align:center; padding:10px; border:1px solid #eee; border-radius:8px;">
                        <span class="tag blue">Monitor</span>
                        <p style="margin-top:10px;"><strong>Blood Pressure:</strong> HRT may have beneficial effect compared to combined contraceptive pill.</p>
                    </div>
                </div>
            </div>
        </section>

    </main>

    <footer>
        <p><strong>Peer reviewed by Dr Philippa Vincent, MRCGP | Last updated 20 Jan 2025</strong></p>
        <p>Based on UK and European Guidelines. For medical professionals use only.</p>
    </footer>

</div>

<script>
    // --- Tab Switching Logic ---
    function switchTab(tabId, btnElement) {
        // Remove active class from all sections
        const sections = document.querySelectorAll('.content-section');
        sections.forEach(sec => sec.classList.remove('active'));

        // Add active class to target section
        document.getElementById(tabId).classList.add('active');

        // Remove active class from all buttons
        const buttons = document.querySelectorAll('.tab-btn');
        buttons.forEach(btn => btn.classList.remove('active'));

        // Add active class to clicked button
        btnElement.classList.add('active');
    }

    // --- Search/Filter Logic ---
    function filterContent() {
        const input = document.getElementById('searchInput');
        const filter = input.value.toLowerCase();
        const sections = document.querySelectorAll('.content-section');
        
        // We need to decide which tab to show if a search matches something in a hidden tab.
        // For simplicity, we will iterate through all cards in all tabs.
        // If a match is found, we highlight the card or hide others.
        
        let firstMatchTabId = null;

        sections.forEach(section => {
            const cards = section.querySelectorAll('.card, .banner, .data-table-container');
            let hasVisibleContent = false;

            cards.forEach(card => {
                const text = card.innerText.toLowerCase();
                if (text.includes(filter)) {
                    card.style.display = 'block';
                    hasVisibleContent = true;
                    // Optional: Highlight text matches (simple implementation)
                    // In a real app, you'd wrap the text in a span. 
                    // Here we just ensure the card is visible.
                } else {
                    card.style.display = 'none';
                }
            });

            // If we are searching, we might want to show the tab containing results?
            // This implementation keeps the user on the current tab but filters content.
            // Better approach: Auto-switch to tab with results if filtering.
            
            if (filter.length > 0 && hasVisibleContent && firstMatchTabId === null) {
                // Determine which tab ID this section belongs to
                if(section.classList.contains('active')) {
                    // Do nothing, already here
                } else {
                    // Find the button that opens this section and click it
                    const sectionId = section.id;
                    const correspondingBtn = document.querySelector(`.tab-btn[onclick*="${sectionId}"]`);
                    if(correspondingBtn) {
                        correspondingBtn.click();
                    }
                }
                firstMatchTabId = section.id;
            }
        });

        // Reset displays if search is cleared
        if (filter === "") {
            sections.forEach(section => {
                const cards = section.querySelectorAll('.card, .banner, .data-table-container');
                cards.forEach(card => card.style.display = 'block'); // Or flex/block depending on element
                // Fix for tables/banners which might need block
                document.querySelectorAll('.banner').forEach(b => b.style.display = 'flex');
                document.querySelectorAll('.data-table-container').forEach(t => t.style.display = 'block');
            });
        }
    }
</script>

</body>
</html>